Signaling Pathways - Vascular Disrupting Agents (VDA) - Sphingosine kinases (SphKs) - calcium uptake - DNA-PK
清除全部
- B6099 LY3023414Target: Akt|PI3K|mTOR|DNA-PKSummary: I类PI3K,mTOR和DNA-PK抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2298 Plinabulin (NPI-2358)中文名: 普那布林Target: Vascular Disrupting Agents (VDA)Summary: 血管破坏剂
- B1640 Torin 21 CitationTarget: mTOR|DNA-PK|ATM/ATRSummary: MTOR抑制剂
- B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8649 NU 7026Target: PI3K|DNA-PK|ATMSummary: 有效的、竞争性DNA-PK抑制剂
- A8626 ETP-46464Target: PI3K|mTOR|DNA-PK|ATM/ATRSummary: ATR抑制剂
- A8510 Ranolazine1 Citation中文名: 雷诺嗪Target: calcium uptakeSummary: 抗缺血
- A8315 NU7441 (KU-57788)4 CitationTarget: PI3K|DNA-PKSummary: DNA-PK抑制剂